Home / Stocks / Rossari Biotech Limited
ROSSARI

Rossari Biotech Limited Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹428.0

Change

-4.75 (-1.1%)

Open

₹428.5

Prev. Close

₹432.75

Day High

₹433.95

Day Low

₹425.0

Volume Analysis

Traded

61,439

Delivered

40,101

Delivery %

65.27%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (0)

No signal for this stock

Opportunities (0)

No signal for this stock

Threats (1)

  • •FII holding has been falling

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹441.91 ₹437.93 ₹432.96 ₹428.98 ₹424.01 ₹420.03 ₹415.06
Fibonacci ₹437.93 ₹434.51 ₹432.4 ₹428.98 ₹425.56 ₹423.45 ₹420.03
Camarilla ₹430.46 ₹429.64 ₹428.82 ₹428.98 ₹427.18 ₹426.36 ₹425.54

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-26.1%

1 Week

-0.44%

1 Month

+2.66%

3 Months

-14.7%

6 Months

-18.32%

1 Year

-30.87%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹180.49

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

18.94%

Net margin 5.75% × asset turnover 1.83x × equity multiplier 1.8x

Company Overview

Sector

Chemicals

Market Cap

₹2,371 Cr

P/E (TTM)

15.5

ROE

10.8%

Book Value

₹254.0

Face Value

₹2.0

Source: Screener.in (Consolidated figures) — data as of 20 Nov 2026. Not investment advice.

TopFund Analysis

Rossari Biotech Limited lands in the middle of the pack on TopFund's composite fundamentals check within the Chemicals sector, at 52/100. The strongest factor is Financial Strength (100/100), while Cash Flow (6/100) is the weakest area to weigh before deciding. FII holding has been falling.

TopFund Score — Fundamentals Quality

52/100 — Average

Data confidence: 80/100 (High Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

100

Growth

70

Valuation

60

Cash Flow

6

Corporate Governance

60

Momentum

22

Institutional Ownership

21

Business Quality

54

Risk & Volatility

40

Liquidity

51

From Screener.in

  • +Company's working capital requirements have reduced from 62.4 days to 48.6 days
  • −Company has a low return on equity of 12.0% over last 3 years.
  • −Dividend payout has been low at 2.00% of profits over last 3 years

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Intimation of Transcript of Q2 & H1 FY27 for the Earnings Conference Call held on October 19, 2026

Audio recording of Q2 and H1 FY27 earnings conference call made available on Rossari website.

Intimation of Q2 & H1 FY27- Earnings Presentation

Rossari reported Q2 FY27 revenue of Rs 697.6 crore, EBITDA Rs 87 crore, and approved KSA greenfield facility leasing.

Newspaper publication of extract of Consolidated Unaudited Financial Results for the quarter and half year ended September 30, 2026.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 483 464 473 490 498 513 580 544 586 582 685 697 698
Expenses + 420 400 409 425 432 448 510 476 514 513 608 617 611
Operating Profit 64 64 64 65 66 65 69 68 72 69 77 81 87
OPM % 13.0% 14.0% 13.0% 13.0% 13.0% 13.0% 12.0% 12.0% 12.0% 12.0% 11.0% 12.0% 12.0%
Other Income + 1 4 1 1 1 1 2 2 2 1 20 4 1
Interest 5 4 3 4 4 5 6 6 6 8 9 11 9
Depreciation 15 15 16 15 15 18 18 18 18 20 24 26 30
Profit before tax 45 48 46 47 48 42 48 46 50 43 64 48 49
Tax % 26.0% 28.0% 25.0% 26.0% 27.0% 25.0% 28.0% 27.0% 26.0% 23.0% 28.0% 26.0% 21.0%
Net Profit + 33 34 34 35 35 32 34 34 37 33 46 35 39
EPS in Rs 6 6 6 6 6 6 6 6 7 6 8 6 7
Raw PDF — — — — — — — — — — — — —
YoY Sales growth 14 19 16 19 3 11 23 11 18 13 18 28 19

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2011 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 122 178 233 292 516 600 709 1,483 1,656 1,831 2,080 2,396 2,661
Expenses + 108 166 209 247 438 495 586 1,299 1,433 1,581 1,815 2,110 2,348
Operating Profit 13 12 24 45 78 105 124 184 223 250 265 286 314
OPM % 11.0% 7.0% 10.0% 15.0% 15.0% 17.0% 17.0% 12.0% 13.0% 14.0% 13.0% 12.0% 12.0%
Other Income + 0 0 1 1 1 4 9 13 6 8 5 24 25
Interest 3 3 2 1 3 4 3 13 22 19 18 29 36
Depreciation 5 4 4 5 12 17 23 48 63 60 67 79 99
Profit before tax 6 5 19 39 63 88 107 136 144 178 185 203 204
Tax % 11.0% 29.0% 17.0% 27.0% 28.0% 26.0% 25.0% 28.0% 26.0% 26.0% 26.0% 26.0% —
Net Profit + 5 3 16 29 46 65 80 98 107 131 136 149 153
EPS in Rs 1 1 3 6 9 13 15 18 19 24 25 27 28
Dividend Payout % 1.0% 0.0% 1.0% 0.0% 0.0% 4.0% 3.0% 3.0% 3.0% 2.0% 2.0% 2.0% —
Sales growth — — 31 25 — 16 18 109 12 11 14 15 20

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2011 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 27 41 56 85 119 277 398 794 904 1,037 1,174 1,322 1,397
Borrowings + 38 22 24 22 8 67 0 8 74 119 218 436 388
Other Liabilities + 24 37 37 49 118 118 152 442 375 401 482 505 564
Total Liabilities 93 104 122 160 250 471 561 1,255 1,364 1,567 1,886 2,274 2,359
Fixed Assets + 43 36 37 44 74 94 181 607 585 578 598 784 845
CWIP 0 8 8 10 3 22 0 1 16 47 140 173 156
Investments 0 0 0 3 0 18 0 36 51 63 84 62 30
Other Assets + 50 60 77 103 173 338 379 611 712 880 1,063 1,254 1,328
Total Assets 93 104 122 160 250 471 561 1,255 1,364 1,567 1,886 2,274 2,359
Equity Capital 4 4 4 4 4 10 10 11 11 11 11 11 11

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2011 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 0 23 2 22 71 57 48 29 152 43 137 65
Cash from Investing Activity + 0 -5 -6 -16 -37 -190 -37 -299 -181 -103 -183 -220
Cash from Financing Activity + 0 -18 3 -6 -29 157 -25 292 61 16 65 186
Net Cash Flow 0 1 0 -1 5 23 -14 22 32 -44 19 31
Free Cash Flow 0 19 -3 8 27 -19 -8 -7 120 -83 -21 -175
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 0 202 22 72 118 74 64 43 89 39 74 47

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 68.34% → 68.14%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 9.45% 9.9% 10.98% 10.64% 10.6% 10.24% 10.5% 10.95% 11.25% 11.46% 15.19% 15.84%
Promoters 68.34% 68.32% 68.32% 68.27% 68.19% 68.18% 68.18% 68.18% 68.15% 68.15% 68.14% 68.14%
FII 4.14% 4.02% 3.83% 3.74% 3.74% 3.98% 3.48% 2.7% 2.32% 2.18% 2.03% 1.84%
DII 18.06% 17.74% 16.87% 17.34% 17.47% 17.59% 17.84% 18.18% 18.25% 18.21% 14.64% 14.19%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Chemicals — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Rossari Biotech Limited (this stock) 2,371 15.5 1.69 10.8%
Bhagiradha Chem & Inds L 2,414 88.0 3.37 2.63%
Nocil Limited 2,285 28.0 1.27 2.84%
J.g.chemicals Limited 2,225 25.4 3.81 13.5%
Jubilant Agri N Con Pro L 2,677 24.9 5.07 33.2%
Nacl Industries Limited 2,749 327.0 3.9 2.37%
Gsp Crop Science Limited 1,980 22.0 2.39 16.5%

Which Mutual Funds Hold Rossari Biotech Limited?

Frequently Asked Questions about Rossari Biotech Limited

Community Sentiment

What are other investors saying about Rossari Biotech Limited?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.